Between The Lines
A journal club review of “Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in phase 3 randomized clinical trial in patients with narcolepsy,” by Kushida CA, et al.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Personalized Medicine in Schizophrenia: Moving Beyond Diagnosis to Patient-Centered Care
2
Psychiatry’s Medication Pipeline in Motion
3
Borderline Personality Disorder: Retaining the Name for Diagnostic Clarity
4
What Clinicians Need to Know About the Federal Push for Deprescribing: A Conversation With Joseph F. Goldberg, MD
5